Home Cart Sign in  
Chemical Structure| 1256580-46-7 Chemical Structure| 1256580-46-7

Structure of Alectinib
CAS No.: 1256580-46-7

Chemical Structure| 1256580-46-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alectinib (CH5424802) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively. Alectinib demonstrates effective central nervous system (CNS) penetration.

Synonyms: CH5424802; RO5424802; RG7853

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Zhengbo Song ; Shifeng Lian ; Silvia Mak ; Maggie Zi-Ying Chow ; Chunwei Xu ; Wenxian Wang , et al.

Abstract: Introduction: Gene fusion variants in ALK-rearranged NSCLC may predict patient outcomes, but previous results have been inconclusive. Fusion isoforms coexisting in the same tumor may affect the efficacy of targeted therapy, but they have not been investigated. Methods: Patients with ALK-rearranged NSCLC who received crizotinib treatments were recruited. Precrizotinib tumor tissues were analyzed by the anchored multiplex polymerase chain reaction for targeted RNA sequencing. Kaplan-Meier and Cox regression were used to compare overall and progression-free survivals. Results: Of the 51 studied subjects, EML4-ALK variant types v1, v2, v3, and others were detected in 23 (45.1%), five (9.8%), 19 (37.3%), and four patients (7.8%), respectively. Multiple EML4-ALK RNA isoforms were detected in 24 tumors (47.1%), and single isoform in 27 (52.9%). Most of the v3 tumors (16 of 19) harbored both v3a and v3b RNA isoforms. Multiple isoforms were also detected in eight non-v3 tumors (33.3% of all 24 multiple isoforms; five v1, two v5′, and one v2). Compared with patients with single isoform, those with multiple isoforms had worse progression-free (hazard ratio and 95% confidence interval: 2.45 [1.06–5.69]) and overall (hazard ratio [95% confidence interval]: 3.74 [1.26–11.13]) survivals after adjusting for potential confounders including variant type. Using the patient-derived H2228 cells known to express v3a and v3b, our single-cell polymerase chain reaction detected either v3a or v3b in most single cells. Treatment of H2228 cells by three ALK inhibitors revealed increased ratios of v3a-to-v3b expression over time. Conclusions: Intratumoral EML4-ALK isoforms may predict the efficacy of targeted therapy in ALK-rearranged NSCLC. Temporal changes of intratumoral fusion isoforms may result from differential selection pressures that a drug might have on one isoform over another. Larger studies on fusion heterogeneity using RNA sequencing are warranted.

Keywords: RNA sequencing ; ALK fusion heterogeneity ; Fusion isoforms ; Crizotinib ; ALK TKI

Purchased from AmBeed: ;

Alternative Products

Product Details of Alectinib

CAS No. :1256580-46-7
Formula : C30H34N4O2
M.W : 482.62
SMILES Code : N#CC1=CC2=C(C=C1)C3=C(C(C)(C)C4=CC(N5CCC(N6CCOCC6)CC5)=C(CC)C=C4C3=O)N2
Synonyms :
CH5424802; RO5424802; RG7853
MDL No. :MFCD19440988
InChI Key :KDGFLJKFZUIJMX-UHFFFAOYSA-N
Pubchem ID :49806720

Safety of Alectinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Alectinib

RTK

Isoform Comparison

Biological Activity

Target
  • ALK

    ALK (F1174L), IC50:3.5 nM

    ALK, IC50:1.9 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03498521 Cancer of Unknown Primary Site Phase 2 Recruiting April 16, 2022 -
NCT01634763 Tumors Characterized by Geneti... More >>c Alterations in Anaplastic Lymphoma Kinase (ALK) Less << Phase 1 Completed - Japan ... More >> Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Koto, Tokyo, Japan, 135-8550 Novartis Investigative Site Fukuoka, Japan, 811-1395 Less <<
NCT03158389 Glioblastoma, Adult Phase 1 Phase 2 Recruiting September 30, 2024 Germany ... More >> Charité Berlin, Neurosurgery Not yet recruiting Berlin, Germany Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic Not yet recruiting Bochum, Germany University Hospital Bonn, Neurology Clinic Not yet recruiting Bonn, Germany University Hospital Cologne, Neurosurgery Not yet recruiting Cologne, Germany University Hospital Dresden, Neurosurgery Not yet recruiting Dresden, Germany University Hospital Essen, Neurology Clinic Not yet recruiting Essen, Germany University Hospital Frankfurt, Neurooncology Not yet recruiting Frankfurt am Main, Germany University Hospital Heidelberg, Neurology Clinic Recruiting Heidelberg, Germany University Hospital Saarland, Neurosurgery Not yet recruiting Homburg, Germany University Hospital Mainz, Neurosurgery Not yet recruiting Mainz, Germany University Hospital Mannheim, Neurology Clinic Not yet recruiting Mannheim, Germany University Hospital Regensburg, Neurology Clinic Not yet recruiting Regensburg, Germany University Hospital Tuebingen, Neurooncology Not yet recruiting Tübingen, Germany Less <<
NCT03087448 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting March 2021 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Less <<
NCT03737994 ALK Gene Rearrangement ... More >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Less << Phase 2 Not yet recruiting December 13, 2025 -
NCT02314481 Non-small Cell Lung Cancer Phase 2 Recruiting January 2023 United Kingdom ... More >> Univeristy College London Hospital Recruiting London, United Kingdom Contact: Amy Smith Less <<
NCT03178552 Non-Small Cell Lung Cancer Phase 2 Phase 3 Recruiting January 2, 2022 -
NCT02706626 Non-Small Cell Lung Cancer Phase 2 Recruiting January 2020 United States, Colorado ... More >> University Of Colorado Recruiting Denver, Colorado, United States, 80045 Contact: Anna Wynfield    720-848-5278    anna.wynfield@ucdenver.edu    Contact: Paula Fisk    720-848-0676    Paula.Fisk@ucdenver.edu    Principal Investigator: David R Camidge, MD          United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Debra Shoemaker, RN    919-681-4768    Debra.shoemaker@duke.edu    Principal Investigator: Thomas E Stinchcombe, MD          United States, Tennessee Vanderbilt Unversity Medical Center Recruiting Nashville, Tennessee, United States, 37203 Contact: Kathy Taylor    615-875-0060    kathy.l.taylor@vanderbilt.edu    Principal Investigator: Leora Horn, MD          United States, Texas University of Texas, Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Jessica Saltarski    214-648-1688    Jessica.Saltarski@UTSouthwestern.edu    Principal Investigator: David Gerber, MD Less <<
NCT03535740 ALK-positive Advanced NSCLC Phase 2 Not yet recruiting April 22, 2022 -
NCT02450903 Non-Small-Cell Lung Cancer Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 811-1395 Novartis Investigative Site Akashi, Hyogo, Japan, 673-8558 Novartis Investigative Site Sakyo-ku, Kyoto, Japan, 606 8507 Novartis Investigative Site Natori, Miyagi, Japan, 981-1293 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Sayama, Osaka, Japan, 589-8511 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Less <<
NCT03546894 - Recruiting June 14, 2021 United States, Massachusetts ... More >> EmpiraMed, Inc. Recruiting Maynard, Massachusetts, United States, 01754 Less <<
NCT01981005 Healthy Volunteer Phase 1 Completed - Netherlands ... More >> Zuidlaren, Netherlands, 9471 GP Less <<
NCT01940510 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT02091141 Neoplasms Sol... More >>id Tumors Biliary Cancer Salivary Cancer Bladder Cancer Less << Phase 2 Recruiting March 31, 2021 -
NCT02604342 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT02074553 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT02074553 - Completed - -
NCT02271139 Non-Small Cell Lung Cancer NO_LONGER_AVAILABLE - University of Alabama, Bimingh... More >>am, Alabama, 35226, United States|Southern Cancer Center, Daphne, Alabama, 36526, United States|Southern Cancer Center, Mobile, Alabama, 36607, United States|Southern Cancer Center - Mobile, Mobile, Alabama, 36608, United States|Southern Cancer Center, PC, Mobile, Alabama, 36608, United States|Lalita Pandit Inc., Fountain Valley, California, 92708, United States|University of California San Diego Medical Center; Moores Cancer Center, La Jolla, California, 92037, United States|Loma Linda Cancer Center, Loma Linda, California, 92354, United States|LAC USC Medical Center, Los Angeles, California, 90033, United States|University of Southern California, Los Angeles, California, 90033, United States|University of California Irvine Medical Center, Orange, California, 92868, United States|St. Joseph Heritage Healthcare, Sebastopol, California, 95472, United States|Innovative Clinical Research Institute, Whittier, California, 90603, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Chicago Hospital, Chicago, Illinois, 60637, United States|Loyola University Med Center, Maywood, Illinois, 60153, United States|Investigative Clin Rsch of IN, Indianapolis, Indiana, 46260, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Partners Can Ctr, Boston, Massachusetts, 02115-6084, United States|Beth Israel Deaconess Med Ctr; Hem/Onc, Boston, Massachusetts, 02215, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Karmanos Cancer Institute - Farmington Hills/Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Henry Ford Health System, West Bloomfield, Michigan, 48322, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Comprehensive Cancer Care, P.C., St. Louis, Missouri, 63141, United States|Billings Clinic Cancer Center; Billings Cancer Research, Billings, Montana, 59101, United States|San Juan Oncology Associates, Farmington, New Mexico, 87401, United States|Columbia University Medical Center; Clinical Research Management Office, New York, New York, 10032, United States|W.G. Bill Hefner VA Medical Center, Salisbury, North Carolina, United States|Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|Tulsa Cancer Institute, Tulsa, Oklahoma, 74146, United States|Oregon Health & Science Uni, Portland, Oregon, 97239, United States|Forbes Hospital, Monroeville, Pennsylvania, 15146, United States|Allegheny Valley Hospital, Natrona Heights, Pennsylvania, 15065, United States|Cancer Treatment Centers of America - Eastern Regional Medical Center, Philadelphia, Pennsylvania, 19124, United States|Allegheny Cancer Center, Pittsburgh, Pennsylvania, 15212, United States|West Penn Cancer Institute, Pittsburgh, Pennsylvania, 15224, United States|Medical University of South Carolina; Hollings Cancer Center, Charleston, South Carolina, 29425, United States|UT Southwestern Medical Center, Dallas, Texas, 75390-8813, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|University of Washington Seattle Cancer Care Alliance, Seattle, Washington, 98195, United States|Northwest Medical Specialties, Tacoma, Washington, 98405, United States|University of Wisconsin; Oncology, Madison, Wisconsin, 53792, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States Less <<
NCT03155009 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2019-09-26 CHU Angers, Angers, 49933, Fra... More >>nce|Hopital Jean Minjoz; Pneumologie, Besancon, 25030, France|Hopital Augustin Morvan; Oncologie Thoracique, Brest, 29609, France|Centre Francois Baclesse; Comite 3, Caen, 14076, France|Centre Hospitalier Intercommunal; Service de Pneumologie, Creteil, 94010, France|H?pital Nord Michallon; Pneumologie, La Tronche, 38700, France|CHRU Lille Service de Pneumologie et Oncologie Thoracique, Lille, 59000, France|H?pital Nord - AP-HM Marseille#, Marseille, 13915, France|Hopital Emile Muller;Pneumologie, Mulhouse, 68070, France|Institut Curie, Paris, 75005, France|Hopital Tenon;Pneumologie, Paris, 75970, France|CHU de Bordeaux, Pessac, 33600, France|Hopital de Pontchaillou; Service de Pneumologie, Rennes, 35033, France|CHU de Rouen - H?pital Charles Nicolle, Rouen, 76031, France|CHU de Toulouse - H?pital Larrey; Service de pneumologie et oncologie pneumologique, Toulouse cedex 9, 31100, France|Hopital Robert Schuman; Pneumologie, Vantoux, 57070, France Less <<
NCT03456076 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting September 30, 2026 -
NCT02023125 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT01940510 - Completed - -
NCT02023125 - Completed - -
NCT03194893 Neoplasms Phase 3 Recruiting June 12, 2024 -
NCT02604342 - Completed - -
NCT01984229 Healthy Volunteer Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT01984229 - Completed - -
NCT02075840 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting January 21, 2020 -
NCT01801111 - Completed - -
NCT02013219 Non-Small Cell Lung Cancer Phase 1 Active, not recruiting January 18, 2019 United States, California ... More >> UC Irvine Medical Center Orange, California, United States, 92868 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06510 United States, Florida Florida Hospital Cancer Inst Orlando, Florida, United States, 32804 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr; Neurology/MS Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Center; Department of Oncology Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering - Basking Ridge New York, New York, United States, 10065 United States, Ohio Case Western Reserve University; Medicine-Hematology and Oncology Cleveland, Ohio, United States, 44106 United States, South Carolina Greenville Health System Greenville, South Carolina, United States, 29605 France Institut Gustave Roussy Villejuif, France, 94805 Hong Kong The Chinese University of Hong Kong Shatin, Hong Kong, 123456 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 03080 Asan Medical Center Seoul, Korea, Republic of, 05505 Spain START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 United Kingdom Queen Mary University of London London, United Kingdom, EC1M 6BQ Less <<
NCT02838420 Anaplastic Lymphoma Kinase-pos... More >>itive Non-small Cell Lung Cancer Less << Phase 3 Active, not recruiting December 6, 2019 China ... More >> Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China, 100021 Beijing Cancer Hospital Beijing, China, 100142 Beijing Chest Hospital; Oncology Department Beijing, China, 101149 Jilin Cancer Hospital Changchun, China, 130012 the First Hospital of Jilin University Changchun, China, 130021 West China Hospital, Sichuan University Chengdu, China, 610041 Third Affiliated Hospital of Third Military Medical University ChongQing, China, 400042 Second Affiliated Hospital of Third Military Medical University Chongqing, China Sun Yet-sen University Cancer Center Guangzhou, China, 510060 Guangdong General Hospital Guangzhou, China, 510080 The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China, 510120 The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, China, 310003 Zhejiang Cancer Hospital Hangzhou, China, 310022 Harbin Medical University Cancer Hospital Harbin, China, 150081 Jiangsu Cancer Hospital Nanjing, China, 210009 The Affiliated Hospital of Medical College Qingdao University Qingdao, China, 266003 Shanghai chest hospital Shanghai, China, 200030 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Shanghai Pulmonary Hospital Shanghai, China, 200433 Korea, Republic of CHA Bundang Medical Center Gyeonggi-do, Korea, Republic of, 13496 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 03181 Asan Medical Center Seoul, Korea, Republic of, 05505 Samsung Medical Center Seoul, Korea, Republic of, 6351 Thailand Rajavithi Hospital; Division of Medical Oncology Bangkok, Thailand, 10400 Ramathibodi Hospital; Dept of Med.-Div. of Med. Onc Bangkok, Thailand, 10400 Khon Kaen University Khon Kaen, Thailand, 40002 Songklanagarind Hospital; Department of Internal Medicine, Division of Respiratory Songkhla, Thailand, 90110 Less <<
NCT03596866 ALK-positive Advanced NSCLC Phase 3 Not yet recruiting September 4, 2023 -
NCT03131206 ALK-positive Non-small Cell Lu... More >>ng Cancer (NSCLC)|RET-positive Non-small Cell Lung Cancer (NSCLC)|RET-positive Thyroid Cancer Less << PHASE1|PHASE2 TERMINATED 2019-04-08 University of California, Irvi... More >>ne, Irvine, California, 92697-7600, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT01871805 Non-Small Cell Lung Cancer PHASE1|PHASE2 COMPLETED 2017-08-31 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|University of California Irvine, Irvine, California, 92697, United States|UCSD Moores Cancer Center, La Jolla, California, 92093, United States|Loma Linda Cancer Center, Loma Linda, California, 92354, United States|UCLA, Los Angeles, California, 90095, United States|Univ of Colorado Canc Ctr, Aurora, Colorado, 80045, United States|National Jewish Health, Denver, Colorado, 80206, United States|Lynn Regional Cancer Center West, Boca Raton, Florida, 33486, United States|Florida Hospital Cancer Inst, Orlando, Florida, 32804, United States|UF Health Orlando, Orlando, Florida, 32806, United States|H. Lee Moffitt Cancer Center and Research Inst., Tampa, Florida, 33612, United States|University of Illinois Cancer Center, Chicago, Illinois, 60612, United States|Monroe Medical Associates; Ingalls Memorial Hosp, Harvey, Illinois, 60426, United States|Massachussets General Hospital, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Can Ins, Boston, Massachusetts, 02215, United States|Newton-Wellesley Hospital, Newton, Massachusetts, 02462, United States|St. Joseph Mercy Hospital; Cancer Care Center., Ann Arbor, Michigan, 48106, United States|Wayne State Uni ; Karmanos Cancer Center, Detroit, Michigan, 48201, United States|Hackensack Univ Med Ctr, Hackensack, New Jersey, 07601, United States|Roswell Park Cancer Inst., Buffalo, New York, 14263, United States|Memorial Sloan-Kettering Cancer Center, Commack, New York, 11725, United States|Richmond University Medical Center; Pharmacy Department, Staten Island, New York, 10310, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Providence Portland Med Ctr, Portland, Oregon, 97213, United States|Oregon Health & Science Uni, Portland, Oregon, 97239, United States|St. Luke's Hospital; Pharmacy Department, Bethlehem, Pennsylvania, 18015, United States|Penn State Hershey Cancer Institute, Hershey, Pennsylvania, 17033, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Cancer Pavillion, Pittsburgh, Pennsylvania, 15232, United States|MUSC Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Center for Biomedical Research LLC, Knoxville, Tennessee, 37909, United States|Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Swedish Cancer Inst., Seattle, Washington, 98104, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Lakeridge Health Oshawa; Oncology, Oshawa, Ontario, L1G 2B9, Canada|McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, H3T 1E2, Canada Less <<
NCT01801111 Non-Small-Cell Lung Carcinoma Phase 1 Phase 2 Completed - -
NCT03202940 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting August 30, 2020 United States, Massachusetts ... More >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alice T Shaw, MD, PhD    617-643-0563    Ashaw1@partners.org    Principal Investigator: Alice T Shaw, MD, PhD Less <<
NCT02521051 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 1 Phase 2 Recruiting June 2022 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Justin L. Gainor, MD    617-724-4000    jgainor@partners.org    Principal Investigator: Justin Gainor, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02155 Contact: Daniel Costa, MD, PhD, MMSc    617-667-9236    dbcosta@bidmc.harvard.edu    Principal Investigator: Daniel Costa, MD, PhD, MMSc Less <<
NCT03445000 Non-small Cell Lung Cancer|Non... More >>-small Cell Lung Cancer Metastatic|Non-small Cell Lung Cancer Recurrent Less << PHASE2 TERMINATED 2021-03-31 Institut Jules Bordet, Brussel... More >>s, Belgium|St. James Hospital, Dublin, Ireland|IRCCS Instituto Tumori Giovanni Paolo II, Bari, Italy|Instituto Europeo di Oncologia (IEO), Milano, Italy|University Hospital of Turin, Turin, Italy|Universita di Verona, Verona, Italy|The Netherlands Cancer Institute Amsterdam, Amsterdam, Netherlands|University Medical Center Maastricht, Maastricht, Netherlands|Hospital general de Alicante, Alicante, Spain|Vall d'Hebron University Hospital, Barcelona, 08035, Spain|Hospital Quirón Dexeus, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Teresa Herrara, La Coruna, Spain|Hospital Puerta de Hierro, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Regional Universitario Carlos Haya, Málaga, Spain|HFR Fribourg, Fribourg, Switzerland|H?pital Universitaire de Genève, Genève, Switzerland|UniversitatSpital Zurich, Zurich, Switzerland Less <<
NCT02075840 - Active, not recruiting - -
NCT03271554 Non-Small Cell Lung Cancer COMPLETED 2021-05-28 Inje University Busan Paik Hos... More >>pital, Busan, 47392, Korea, Republic of|Dong-A University Hospital, Busan, 49201, Korea, Republic of|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Kosin University Gospel Hospital, Busan, 49267, Korea, Republic of|Dongnam Institute of Radiological & Medical Sciences, Busan, Korea, Republic of|Chungbuk National University Hospital, Cheongju-si, 28644, Korea, Republic of|Kyungpook National University Chilgok Hospital, Daegu, 41404, Korea, Republic of|Keimyung University Dongsan Medical Center, Daegu, 41931, Korea, Republic of|Daegu Catholic University Medical Center, Daegu, 42472, Korea, Republic of|Konyang University Hospital, Daejeon, 35365, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Gangwon-do, 26426, Korea, Republic of|Inje University Ilsan Paik Hospital, Gyeonggi-do, 10380, Korea, Republic of|Uijeongbu St. Mary's Hospital, Gyeonggi-do, 11765, Korea, Republic of|CHA Bundang Medical Center, Gyeonggi-do, 13496, Korea, Republic of|Hallym University Sacred Heart Hospital, Gyeonggi-do, 14068, Korea, Republic of|Bucheon St Mary's hospital, Gyeonggi-do, 14647, Korea, Republic of|St. Vincent's Hospital, Gyeonggi-do, 16247, Korea, Republic of|Pusan National University Yangsan Hospital, Gyeongsangnam-do, 50612, Korea, Republic of|Catholic Univ. of Incheon St.Mary's Hospital, Incheon, 21431, Korea, Republic of|Gachon University Gil Medical Center, Incheon, 21565, Korea, Republic of|Inha University Hospital, Incheon, 22332, Korea, Republic of|Chonbuk National University Hospital, Jeollabuk-do, 54907, Korea, Republic of|Chonnam National University Hwasun Hospital, Jeollanam-do, 58128, Korea, Republic of|Inje University, Sanggye-Paik Hospital, Seoul, 01757, Korea, Republic of|Kyung Hee University Hospital, Seoul, 02447, Korea, Republic of|Korea University Anam Hospital, Seoul, 02841, Korea, Republic of|Kangbuk Samsung Hospital, Seoul, 03181, Korea, Republic of|Severance Hospital, Yonsei University, Seoul, 03722, Korea, Republic of|Severance Hospital, Seoul, 03722, Korea, Republic of|Gangdong Kyung Hee University Hospital, Seoul, 05278, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Gangnam Severance Hospital, Seoul, 06273, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, 07985, Korea, Republic of|Korea University Guro Hospital, Seoul, 08308, Korea, Republic of|Soon Chun Hyang University Hospital; Department of Pulmonology and Allergy, Seoul, 140-743, Korea, Republic of|Yonsei University Wonju Severance Christian Hospital, Wonju-Si, 220-701, Korea, Republic of Less <<
NCT02621047 Hepatic Impairment PHASE1 COMPLETED 2016-12-08 Pharmaceutical Research Associ... More >>ates CZ, s.r.o., Praha 7, 170 00, Czechia|Summit Clinical Research s.r.o.; Oddelenie internej mediciny a klinickej farmakologie, Bratislava, 831 01, Slovakia Less <<
NCT01871805 Non-Small Cell Lung Cancer PHASE1|PHASE2 COMPLETED 2017-08-31 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|University of California Irvine, Irvine, California, 92697, United States|UCSD Moores Cancer Center, La Jolla, California, 92093, United States|Loma Linda Cancer Center, Loma Linda, California, 92354, United States|UCLA, Los Angeles, California, 90095, United States|Univ of Colorado Canc Ctr, Aurora, Colorado, 80045, United States|National Jewish Health, Denver, Colorado, 80206, United States|Lynn Regional Cancer Center West, Boca Raton, Florida, 33486, United States|Florida Hospital Cancer Inst, Orlando, Florida, 32804, United States|UF Health Orlando, Orlando, Florida, 32806, United States|H. Lee Moffitt Cancer Center and Research Inst., Tampa, Florida, 33612, United States|University of Illinois Cancer Center, Chicago, Illinois, 60612, United States|Monroe Medical Associates; Ingalls Memorial Hosp, Harvey, Illinois, 60426, United States|Massachussets General Hospital, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Can Ins, Boston, Massachusetts, 02215, United States|Newton-Wellesley Hospital, Newton, Massachusetts, 02462, United States|St. Joseph Mercy Hospital; Cancer Care Center., Ann Arbor, Michigan, 48106, United States|Wayne State Uni ; Karmanos Cancer Center, Detroit, Michigan, 48201, United States|Hackensack Univ Med Ctr, Hackensack, New Jersey, 07601, United States|Roswell Park Cancer Inst., Buffalo, New York, 14263, United States|Memorial Sloan-Kettering Cancer Center, Commack, New York, 11725, United States|Richmond University Medical Center; Pharmacy Department, Staten Island, New York, 10310, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Providence Portland Med Ctr, Portland, Oregon, 97213, United States|Oregon Health & Science Uni, Portland, Oregon, 97239, United States|St. Luke's Hospital; Pharmacy Department, Bethlehem, Pennsylvania, 18015, United States|Penn State Hershey Cancer Institute, Hershey, Pennsylvania, 17033, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Cancer Pavillion, Pittsburgh, Pennsylvania, 15232, United States|MUSC Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Center for Biomedical Research LLC, Knoxville, Tennessee, 37909, United States|Texas Oncology-Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Swedish Cancer Inst., Seattle, Washington, 98104, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Lakeridge Health Oshawa; Oncology, Oshawa, Ontario, L1G 2B9, Canada|McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, H3T 1E2, Canada Less <<
NCT02621047 Hepatic Impairment PHASE1 COMPLETED 2016-12-08 Pharmaceutical Research Associ... More >>ates CZ, s.r.o., Praha 7, 170 00, Czechia|Summit Clinical Research s.r.o.; Oddelenie internej mediciny a klinickej farmakologie, Bratislava, 831 01, Slovakia Less <<
NCT04644315 Neoplasms|Colorectal Neoplasms... More >>|Melanoma|Pancreatic Neoplasms|Sarcoma|Ovarian Neoplasms|Brain Neoplasms|Thyroid Neoplasms|Neuroendocrine Tumors|Cholangiocarcinoma|Salivary Gland Neoplasms|Head and Neck Neoplasms|Thyroid Cancer, Papillary|Lymphoma, Large-Cell, Anaplastic|Neoplasms by Site|Respiratory Tract Neoplasms|Thoracic Neoplasms|Respiratory Tract Diseases|Carcinoma, Bronchogenic|Bronchial Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Central Nervous System Less << PHASE2 TERMINATED 2022-05-16 Science 37, Inc, Culver City, ... More >>California, 90230, United States|Science 37-Basem; Dept 004- Basem, Culver City, California, 90230, United States|Science 37-Beg; Dept 001 Dr. M. Beg, Culver City, California, 90230, United States|Science 37-Cannon; Dept 002-Cannon, Culver City, California, 90230, United States|Science 37-Kurzrock; Dept 005-Kurzrock, Culver City, California, 90230, United States|Science 37-Thomas; Dept 006-Thomas, Culver City, California, 90230, United States|Homebased Telemedicine, Los Angeles, California, 90013, United States|Homebased Telemedicine, Sacramento, California, 95814, United States|Homebased Telemedicine, San Diego, California, 92101, United States|Homebased Telemedicine, San Francisco, California, 94104, United States|Homebased Telemedicine, San Jose, California, 95110, United States|Homebased Telemedicine, Jacksonville, Florida, 32202, United States|Homebased Telemedicine, Miami, Florida, 33132, United States|Homebased Telemedicine, Orlando, Florida, 32801, United States|Homebased Telemedicine, Tampa, Florida, 33601, United States|Homebased Telemedicine, Fort Wayne, Indiana, 46802, United States|Homebased Telemedicine, Indianapolis, Indiana, 46202, United States|Homebased Telemedicine, Minneapolis, Minnesota, 55401, United States|Homebased Telemedicine, Saint Paul, Minnesota, 55155, United States|Homebased Telemedicine, Saint Louis, Missouri, 63103, United States|Homebased Telemedicine, Buffalo, New York, 14202, United States|Homebased Telemedicine, New York, New York, 10038, United States|Homebased Telemedicine, Philadelphia, Pennsylvania, 19103, United States|Homebased Telemedicine, Pittsburgh, Pennsylvania, 15282, United States|Homebased Telemedicine, Austin, Texas, 78701, United States|Homebased Telemedicine, Dallas, Texas, 75202, United States|Homebased Telemedicine, Houston, Texas, 77002, United States|Homebased Telemedicine, Richmond, Virginia, 23220, United States|Homebased Telemedicine, Virginia Beach, Virginia, 23451, United States Less <<
NCT05525338 Drug Monitoring|Carcinoma, Non... More >>-Small-Cell Lung|Lung Cancer|Anaplastic Lymphoma Kinase Gene Mutation|Anaplastic Lymphoma Kinase Gene Translocation Less << PHASE4 RECRUITING 2026-12-31 Gustave Roussy, Villejuif, Val... More >>-de-Marne, 94805, France|Radboud University Medical Center, Nijmegen, Gelderland, 6525 GA, Netherlands|Maastricht University Medical Center +, Maastricht, Limburg, 6229 HX, Netherlands|The Netherlands Cancer Institute, Amsterdam, Noord-Holland, 1066 CX, Netherlands|Amsterdam University Medical Center, Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Leiden University Medical Center, Leiden, Zuid-Holland, 2333 ZA, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, 3015 GD, Netherlands|University Medical Center Groningen, Groningen, 9713GZ, Netherlands Less <<
NCT04351334 Non-Small-Cell Lung Carcinoma COMPLETED 2022-11-01 Pfizer Inc, New York, New York... More >>, 10017, United States Less <<
NCT04774718 ALK Fusion-positive Solid or C... More >>NS Tumors Less << PHASE1|PHASE2 RECRUITING 2032-02-28 Lucile Packard Children's Hosp... More >>ital, Palo Alto, California, 94304, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, 33701, United States|University of Michigan, C.S. Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|Children's Minnesota, Minneapolis, Minnesota, 55404, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|St. Jude Children'S Research Hospital, Memphis, Tennessee, 38105, United States|Sydney Children's Hospital, Randwick, New South Wales, 2031, Australia|Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Hospital de Cancer de Barretos, Barretos, S?o Paulo, 14784-400, Brazil|Graacc-Grupo de Apoio ao adolescente e a crianca com cancer, Sao Paulo, S?o Paulo, 04038-030, Brazil|The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|CHU Sainte-Justine, Montreal, Quebec, H3T 1C5, Canada|Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China|Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China|Rigshospitalet, K?benhavn ?, 2100, Denmark|Centre Léon Bérard, Institut d?Hémato-Oncologie Pédiatrique, Lyon, 69373, France|H?pital de la Timone, Oncologie Pédiatrique, Marseille, 13385, France|Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris, Paris, 75248, France|Universit?tsklinikum Heidelberg, Heidelberg, 69120, Germany|Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genova, Liguria, 16147, Italy|Istituto Nazionale Tumori di Milano, Milano, Lombardia, 20133, Italy|Dipartimento di Scienze Pediatriche Adolescenza, Torino, Piemonte, 10126, Italy|Seoul National University Hospital, Seoul, 03080, Korea, Republic of|Asan Medical Center, Seoul, 05505, Korea, Republic of|Samsung Medical Center, Seoul, 06351, Korea, Republic of|Hospital Infantil Universitario Nino Jesus, Madrid, 28009, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41 41013, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Great Ormond Street Hospital, London, WC1N 3JH, United Kingdom|Royal Manchester Childrens Hospital, Manchester, M13 9WL, United Kingdom|Great North Children's Hospital, Newcastle upon Tyne, NE1 4LP, United Kingdom|Royal Marsden Hospital (Sutton), Sutton, SM2 5PT, United Kingdom Less <<
NCT05015010 Non Small Cell Lung Cancer PHASE2 ACTIVE_NOT_RECRUITING 2026-12-28 IRCCS Istituto Scientifico Rom... More >>agnolo per lo Studio e la Cura dei Tumori - I.R.S.T., Meldola, Forlì-Cesena, 47014, Italy|UOC Oncologia Medica Ospedale Versilia USL Toscana Nord Ovest, Lido Di Camaiore, Lucca, 55041, Italy|A.S.S.T - Monza Ospedale San Gerardo, Monza, Monza Brianza, 20900, Italy|Centro di Riferimento Oncologico (CRO) - IRCCS Aviano, Aviano, Pordenone, Italy|SSD oncologia polmonare - AOU San Luigi Gonzaga, Orbassano, Torino, 10043, Italy|IRCCS Istittuo Tumori Giovanni Paolo II, Bari, 70124, Italy|Azienda Ospedaliero Universitaria Policlinico S.Orsola-Malpighi, Bologna, 40138, Italy|Oncologia Medica - PO Rodolico -AOU "Policlinico - Vittorio Emanuele", Catania, 95125, Italy|SODc Oncologia Medica - Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy|Oncologia Medica 2 - IRCCS AOU Policlinico San Martino - IST, Genova, 16132, Italy|Dipartimento Oncologia e Ematologia - Azienda Ospedaliero-Universitaria di Modena, Modena, 41124, Italy|U.O.C Pneumologia ad Indirizzo Oncologico - Azienda Ospedaliera Dei Colli, Napoli, 80131, Italy|Istituto Oncologico Veneto (IOV), Padova, 35128, Italy|UOC di Oncologia Medica - AOU di Parma, Parma, 43126, Italy|Ospedale S. Maria della Misericordia, Perugia, 06129, Italy|IFO Istituto Regina Elena, Roma, 00144, Italy|UOSD Pneumologia Oncologica- Ospedale San Camillo, Roma, 00152, Italy|Fondazione Policlinico Universitario 'A. Gemelli' IRCCS. Università Cattolica del Sacro Cuore, Roma, 00168, Italy|Humanitas Research Hospital - Medical Oncology, Rozzano, 20089, Italy|Dipartimento di Oncologia Medica - Università di Verona, Verona, 37135, Italy Less <<
NCT05770037 Solid Tumor|Haematological Mal... More >>ignancy|Malignant Neoplasm|Lymphoproliferative Disorders|Neoplasms by Histologic Type|Neoplasms by Site|Cancer|Anaplastic Large Cell Lymphoma|Lymphoma|Renal Cell Carcinoma|Neuroblastoma Less << PHASE2|PHASE3 RECRUITING 2025-10-29 Belfast City Hospital, Belfast... More >>, BT9 7AB, United Kingdom|University Hospital Birmingham, Birmingham, B15 2TT, United Kingdom|Birmingham Children's Hospital, Birmingham, United Kingdom|Bristol Royal Hospital for Children, Bristol, BS2 8BJ, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrooke's Hospital, Cambridge, CB2 OQQ, United Kingdom|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|The Beatson Hospital, Glasgow, G12 OYN, United Kingdom|Royal Hospital for Children Glasgow, Glasgow, G51 4TF, United Kingdom|Leeds General Infirmary, Leeds, LS1 3EX, United Kingdom|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom|Alder Hey Hospital, Liverpool, L14 5AB, United Kingdom|The Royal Marsden Hospital, London Borough of Sutton, SM2 5PT, United Kingdom|University College London Hospital, London, NW1 2BU, United Kingdom|Guy's Hospital, London, SE1 9RT, United Kingdom|Great Ormond Street Hospital, London, WC1N 3JH, United Kingdom|Royal Manchester Children's Hospital, Manchester, M13 9WL, United Kingdom|The Christie Hospital, Manchester, M20 4BX, United Kingdom|Great North Children's Hospital, Newcastle, NE1 4LP, United Kingdom|Freeman Hospital, Newcastle, NE7 7DN, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom|John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom|Weston Park Hospital, Sheffield, S10 2SJ, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Clatterbridge Cancer Centre, Wirral, CH63 4JY, United Kingdom Less <<
NCT04764188 NSCLC ACTIVE_NOT_RECRUITING 2027-05-10 Clinica Adventista Belgrano, C... More >>iudad Autonoma Buenos Aires, C1430EGF, Argentina|Lifehouse, Camperdown, New South Wales, 2050, Australia|Liverpool Hospital, Liverpool, New South Wales, 2170, Australia|GenesisCare North Shore, St Leonards, New South Wales, 2065, Australia|Royal North Shore Hospital, St. Leonards, New South Wales, 2065000, Australia|Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia|Peter MacCallum Cancer Center, East Melbourne, Victoria, 3002, Australia|Klinikum Klagenfurt am W?rtersee, Klagenfurt am Worthersee, 9020, Austria|Klinik Penzing, Wien, 1140, Austria|Krankenhaus Nord - Klinik Floridsdorf, Wien, 1210, Austria|CHIREC, Auderghem, 1160, Belgium|AZ Sint Lucas (Sint Lucas), Gent, 9000, Belgium|Jessa Zkh (Campus Virga Jesse), Hasselt, 3500, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|CHU de Liège, Liège, 4000, Belgium|AZ Glorieux- vzw Werken Glorieux, Ronse, 9600, Belgium|Vitaz, Sint Niklaas, 9100, Belgium|Complex Oncology Center Burgas, Burgas, Bulgaria|Multiprofile Hospital for Active Treatment Uni Hospital, Panagyurishte, 4500, Bulgaria|DDODIU-Plovdiv, EOOD, Plovdiv, 4004, Bulgaria|MBAL Serdika EOOD, Sofia, 1632, Bulgaria|Acibadem City Clinic Tokuda, Sofia, Bulgaria|Centro de Estudios Clínicos SAGA, Santiago, 7500653, Chile|Inst. Nacional Del Torax, Santiago, Chile|Hu Nan Provincial Cancer Hospital, Changsha, 410006, China|Sun Yet-sen University Cancer Center, Guangzhou, 510060, China|Guangzhou Panyu Central Hospital, Guangzhou, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou City, 310009, China|Anhui Chest Hospital, Hefei, China|Shandong Cancer Hospital, Jinan, 250117, China|Jiangsu Province Hospital, Nanjing, 210036, China|Guangxi Cancer Hospital of Guangxi Medical University, Nanning, 530021, China|Shanxi Provincial Cancer Hospital, Taiyuan, 030013, China|Taizhou Hospital of Zhejiang Province, Taizhou, 317000, China|Tianjin Cancer Hospital, Tianjin, 300060, China|Tianjin Medical University General Hospital, Tianjin, China|Union Hospital of Tongji Medical College, Dept. of Cancer Center, Wuhan, 430023, China|The Affiliated Hospital of Xuzhou Medical College, Xuzhou, 221004, China|Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C., 110131, Colombia|Hospital Universitario San Ignacio, Bogota, 000472, Colombia|Angiografia del Occidente, Cali, 760045, Colombia|Instituto Cancerología Medellin, Medellin, 050024, Colombia|Clinical Hospital Centre Osijek, Osijek, 31000, Croatia|Clinical Hospital Centre Zagreb, Zagreb, 10000, Croatia|Hospital Hermanos Ameijeiras, La Habana, 10300, Cuba|Instituto Nacional de Oncología y Radiología (INOR), La Habana, 10400, Cuba|Masaryk?v onkologicky ústav, Brno, 656 53, Czechia|Fakultni nemocnice Olomouc, Olomouc, 775 20, Czechia|Thomayerova nemocnice, Praha 4 - Krc, 140 59, Czechia|Tampere University Hospital, Tampere, 33520, Finland|Turku University Hospital, Turku, 20521, Finland|Rambam Health Care Campus, Haifa, 3109601, Israel|Rabin Medical Center, Petach Tikva, 4941492, Israel|Chaim Sheba Medical Center, Ramat Gan, 5262100, Israel|Ichilov Sourasky Medical Center, Tel Aviv, 6423906, Israel|Grande Ospedale Metropolitano, Reggio Calabria, Calabria, 89133, Italy|IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna, 47014, Italy|Fondazione Ptv Policlinico Tor Vergata, Roma, Lazio, 00133, Italy|Policlinico Universitario "Agostino Gemelli", Roma, Lazio, 00168, Italy|AZ. Ospedaliera San Giovanni - Addolorata, Roma, Lazio, 00184, Italy|A.O. Villa Scassi, Genova, Liguria, 16149, Italy|ASST Spedali Civili di Brescia, Brescia, Lombardia, 25123, Italy|Asst Di Cremona, Cremona, Lombardia, 26100, Italy|A.O.U. Maggiore della Carità, Novara, Piemonte, 28100, Italy|Presidio Ospedaliero Centrale, Taranto, Puglia, 74121, Italy|Ospedale Oncologico A.Businco, Cagliari, Sardegna, 09121, Italy|AO Ospedali Riuniti Villa Sofia-Cervello-Presidio Ospedaliero Cervello, Palermo, Sicilia, 90146, Italy|Ospedale San Jacopo, Pistoia, Toscana, 51100, Italy|Clinica Oncologica-Ospedali Riuniti Ancona, Torrette, Toscana, 60020, Italy|Ospedale Silvestrini, Perugia, Umbria, 06122, Italy|Istituto Oncologico Veneto IRCCS, Padova, Veneto, 35128, Italy|Hospital of Lithuanian University of Health Sciences Kaunas Clinics Public Institution, Kaunas, 50009, Lithuania|National Cancer Institute, Vilnius, LT-08660, Lithuania|Instituto Oncológico Nacional (ION), Panama City, 0816-04433, Panama|Oncosalud Sac, Lima, 41, Peru|Instituto Nacional de Enfermedades Neoplasicas, Lima, Lima 34, Peru|Aliada Centro Oncologico, Lima, Peru|Hospital de Sao Joao, Porto, 4200, Portugal|CHVNG/E_Unidade 1, Vila Nova De Gaia, 4434-502, Portugal|Alba Emergency County Hospital, Alba Iulia, 510077, Romania|Emergency University Bucharest Hospital, Bucharest, 050098, Romania|Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca, 400015, Romania|Amethyst Cluj, Cluj-Napoca, Romania|Institutul Regional de Oncologie Iasi, Iasi, 700483, Romania|Spitalul Municipal Ploiesti, Ploiesti, 100337, Romania|Centrul de Oncologie Oncohelp, Timisoara, 300239, Romania|Altai Regional Oncological Center, Barnaul, Altaj, 656049, Russian Federation|Bashkirian Republican Clinical Oncology Dispensary, UFA, Baskortostan, 450054, Russian Federation|Krasnoyarsk Regional Oncology Dispensary n.a. Krizhanovsky, Krasnoyarsk, Krasnodar, 660133, Russian Federation|Chelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk, Moskovskaja Oblast, 454087, Russian Federation|LLC "Oncology scientific centre", Pesochny, Sankt Petersburg, 197758, Russian Federation|Clinic for Pulmonology, Clinical Center of Serbia, Belgrade, 11000, Serbia|University Hospital Medical Center Bezanijska kosa, Belgrade, 11080, Serbia|Clinical Center Nis, Nis, 18 000, Serbia|Institute for pulmonary diseases of Vojvodina, Sremska Kamenica, 21204, Serbia|Adana Baskent University Hospital, Adana, 01120, Turkey|Gulhane Training and Research Hospital, Ankara, 06010, Turkey|Ataturk Sanatoryum Egitim Ve Arastirma Hastanesi, Ankara, 06280, Turkey|Gazi University Medical Faculty, Oncology Hospital, Ankara, 06500, Turkey|Liv Hospital Ankara, Ankara, 06680, Turkey|Ankara City Hospital, Ankara, 06800, Turkey|Antalya Training and Research Hospital, Antalya, 07100, Turkey|Pamukkale University School Of Medicine, Denizli, 20070, Turkey|Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, 22030, Turkey|Kartal Dr Lutfi Kirdar Sehir Hastanesi, Istanbul, 34000, Turkey|Medipol University Medical Faculty, Istanbul, 34214, Turkey|Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, 34384, Turkey|Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi, Izmir, 35110, Turkey|Inonu University Medical Faculty of Medicine, Malatya, 44280, Turkey|Necmettin Erbakan üniversitesi Meram T?p Fakültesi Yunus Emre, Meram, 42080, Turkey|Mediclinic Airport Road Hospital, Abu Dhabi, United Arab Emirates|Mediclinic City Hospital, Dubai, United Arab Emirates|Sanatorio CASMU, Montevideo, Uruguay|Hanoi Oncology Hospital, Hanoi, 100000, Vietnam|K hospital, Hanoi, 100000, Vietnam|Hochiminh city oncology hospital, Hochiminh city, 700000, Vietnam Less <<
NCT04708639 Lung Cancer|ALK Gene Mutation|... More >>Resistance, Disease|Mutation Less << ENROLLING_BY_INVITATION 2025-06-30 Aarhus University Hospital, Aa... More >>rhus, 8200, Denmark Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.07mL

0.41mL

0.21mL

10.36mL

2.07mL

1.04mL

20.72mL

4.14mL

2.07mL

 

Historical Records

Categories